Bradley Moore is a Professor at the University of California San Diego (UCSD), holding dual appointments in the Scripps Institution of Oceanography (Center for Marine Biotechnology and Biomedicine) and the Skaggs School of Pharmacy and Pharmaceutical Sciences . His research focuses on marine chemical biology, natural products chemistry, microbial genomics, and environmental toxicology. He earned a B.S. from the University of Hawaii, a Ph.D. from the University of Washington, and completed postdoctoral training at the University of Zurich. His work spans marine drug discovery, toxin mechanisms, and microbial metabolomics. Notable contributions include elucidating biosynthetic pathways for anticancer agents like salinosporamide A and studying the ecological roles of marine natural products. He actively investigates marine microbiome-driven processes, including coral genome conservation and harmful algal bloom dynamics. Recent publications highlight advancements in genome assembly (e.g., Corallium rubrum), enzymatic mechanisms (diiron oxidases), and toxin prediction models. His lab integrates bioinformatics, synthetic biology, and field studies to address environmental and biomedical challenges. Dr. Moore collaborates across disciplines to advance marine biotechnology and has contributed to initiatives like molecular forecasting of domoic acid blooms. His research emphasizes translating marine natural products into therapeutics while addressing ecological impacts of climate change and pollution.
